The Maryland Prescription Drug Affordability Board is evaluating its cost review study process (COMAR 14.01.04.01, et seq.) and policy review procedures (COMAR 14.01.05.01, et seq.), and invites public comment on these procedures. Under COMAR 14.01.05.04D(1), the Board, through staff, is convening an informational hearing to receive public input.
Informational Hearing:
February 10, 2026 February 10, 2026
1:00 p.m. 6:00 p.m.
Virtual Hearing via Zoom Virtual Hearing via Zoom
Registration to Testify
A person who wishes to provide input by testifying at the hearing shall register here (by google form), by close of business Wednesday, February 4, 2026. The person shall provide their name, address, email, phone number, employer or professional organization (if speaking on an organization’s behalf), and identify the hearing (afternoon/evening) at which they wish to speak. A person may only register to speak at a single hearing.
Registration to Attend/Observe Hearing
A person may register to attend/observe any or all of the scheduled hearings. After registering, you will receive a confirmation email with information about joining the hearing
Any person wishing to attend the February 10, 2026 1:00 p.m. hearing may register here.
Any person wishing to attend the February 10, 2026 6:00 p.m. hearing may register here.
Hearing Mechanics
A specified time limit for testimony has not been set. However, depending on the number of speakers, a reasonable time limit for testimony may be established.
An individual with a disability should contact the Board as soon as possible regarding the need for any accommodation. The Board provides reasonable accommodations for individuals with disabilities with reasonable advance notice.
Call for Testimony and Information
These informational hearings are scheduled to receive input, information, and opinions from the public and stakeholders to help the Board review and improve the cost review study process and policy review procedures.
NOTICE OF REQUEST FOR WRITTEN COMMENTS IN LIEU OF VERBAL TESTIMONY AT THE INFORMATIONAL HEARINGS SCHEDULED FOR FEBRUARY 10, 2026
The Board also requests, under COMAR 14.01.01.05B(4), public written comment, submitted in lieu of verbal testimony, on the cost review study process (COMAR 14.01.04.01, et seq.) and policy review procedures (COMAR 14.01.05.01, et seq.).
Written comments submitted in lieu of verbal testimony must be submitted to [email protected] by Wednesday, February 10, 2026 at 12:00 PM ET. Please utilize the subject line: “Informational Hearing Written Testimony (Cost Review Study Process).”
A PDF of this notice can be found here. 